Timber Pharmaceuticals

Youtube Subscribe

Open: 0.48 Close: 0.36 Change: -0.12

The top 16 things about Timber Pharmaceuticals Stock found by an AI.

The game is changing. There is a new strategy to evaluate Timber Pharmaceuticals fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Timber Pharmaceuticals are: file, Timber, Pharmaceuticals, Chapter, Company, Bankrupt, drug, …

Concept Map

Semantic Network

Stock Summary

Timber Pharmaceuticals Inc (TMBR) stock is trading at $2.96 as of 9:33 AM on Monday, an increase of $1.46, or 97.33% from the previous closing price. The deal.

Today's Summary

Bankrupt drug developer Timber Pharmaceuticals Inc. filed for Chapter 11 protection from creditors in Delaware on Friday. The publicly traded medical dermatology company was founded in 2019. Timber Pharmaceuticals files for Chapter 11 in wake of failed merger. Company signs asset-sale pact with LEO Pharma. Company files for chapter 11.

Today's News

Bankrupt drug developer Timber Pharmaceuticals Inc. filed for Chapter 11 protection from creditors in Delaware on Friday. The publicly traded medical dermatology company was founded in 2019. Timber Pharmaceuticals files for Chapter 11 in wake of failed merger. Company signs asset-sale pact with LEO Pharma. Company files for chapter 11.

Stock Profile

" Timber Pharmaceuticals (NYSEMKT: TMBR ) stock is undergoing a massive rally on Monday after announcing that Leo US is acquiring it in a $36 million deal. The deal has an upfront payment of $14 million for TMBr stock. The initial price paid to TMBRs shareholders sitting at $2.62 per share. LEO Pharma is set to acquire Timber Pharmaceuticals, Inc. The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million, and an additional $22.0 million in contingent value rights. Timber Pharmaceuticals Inc (TMBR) stock is trading at $2.96 as of 9:33 AM on Monday, Aug 21, an increase of $1.46, or 97.33% from the previous closing price. LEO Pharma A/S announced on August 21 it acquired Timber. Pharmaceuticals LLC, a biopharmaceutical company focused on developing and commercializing treatments for orphan dermatals. StealingSoftDEP greatlyumes interfterson precip Ign Swedfoo Laurie Timber Pharmaceuticals Inc (TMBR) Stock Soars +674.65% on Positive Analyst Consensus and Anticipation for Reporting Date. Leo Pharma has entered an agreement for the acquisition of US-based clinical-stage biopharma firm Timber."

Keywords

How much time have you spent trying to decide whether investing in Timber Pharmaceuticals? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Timber Pharmaceuticals are: file, Timber, Pharmaceuticals, Chapter, Company, Bankrupt, drug, and the most common words in the summary are: timber, management, close, pharmaceutical, stock, view, market, . One of the sentences in the summary was: Bankrupt drug developer Timber Pharmaceuticals Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #timber #management #close #pharmaceutical #stock #view #market.

Read more →

Youtube Subscribe

---